Quoin Total Assets from 2010 to 2024

QNRX Stock

USD 0.62 0.01 1.59%

Quoin Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 11.7 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

12.2 M

Current Value

11.7 M

Quarterly Volatility

8.7 M

Credit Downgrade

Yuan Drop

Covid

Check Quoin Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quoin Pharmaceuticals' main balance sheet or income statement drivers, such as Selling General Administrative of 4 M, Total Revenue of 0.0 or Other Operating Expenses of 7 M, as well as many indicators such as Dividend Yield of 7.58, Ptb Ratio of 0.74 or Book Value Per Share of 5.97. Quoin financial statements analysis is a perfect complement when working with Quoin Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Quoin Pharmaceuticals Correlation against competitors.

Latest Quoin Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Quoin Pharmaceuticals Ltd over the last few years. Total assets refers to the total amount of Quoin Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Quoin Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Quoin Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quoin Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 12.17 M

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Total Assets

Timeline

Quoin Total Assets Regression Statistics

	Arithmetic Mean	12,080,950
	Geometric Mean	9,762,998
	Coefficient Of Variation	71.63
	Mean Deviation	5,678,209
	Median	8,819,000
	Standard Deviation	8,653,275
	Sample Variance	74.9T
	Range	32.5M
	R-Value	0.12
	Mean Square Error	79.5T
	R-Squared	0.01
	Significance	0.67
	Slope	229,638
	Total Sum of Squares	1048.3T

Quoin Total Assets History

	2024	11.7 M
	2023	12.2 M
	2022	14.5 M
	2021	9.4 M
	2020	1.4 M
	2019	6.2 M
	2018	30.4 M

Other Fundumenentals of Quoin Pharmaceuticals

Intangibles To Total Assets

Quoin Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Total Current Assets	Net Tangible Assets	Current Deferred Revenue	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Short Term Debt	Intangible Assets	Common Stock	Net Invested Capital	Short Long Term Debt	Net Working Capital
Total Assets		0.92	-0.1	0.56	0.05	0.31	-0.23	-0.02	0.01	-0.22	-0.09	0.06	-0.05	0.02	0.01	0.02
Total Stockholder Equity	0.92		-0.27	0.3	-0.1	0.57	-0.27	-0.24	0.08	-0.52	-0.26	0.27	0.08	-0.16	0.08	-0.15
Net Debt	-0.1	-0.27		0.18	0.13	-0.69	0.08	0.7	0.1	0.5	1.0	-0.2	0.14	0.19	0.1	0.15
Total Current Assets	0.56	0.3	0.18		0.69	0.07	-0.54	0.63	-0.33	0.43	0.19	-0.63	-0.64	0.7	-0.33	0.69
Net Tangible Assets	0.05	-0.1	0.13	0.69		0.08	-0.79	0.78	-0.74	0.66	0.13	-0.96	-0.95	0.99	-0.74	0.99
Current Deferred Revenue	0.31	0.57	-0.69	0.07	0.08		-0.58	-0.37	-0.14	-0.68	-0.68	0.16	-0.2	-0.02	-0.14	0.0
Retained Earnings	-0.23	-0.27	0.08	-0.54	-0.79	-0.58		-0.48	0.7	-0.1	0.08	0.62	0.73	-0.7	0.7	-0.71
Accounts Payable	-0.02	-0.24	0.7	0.63	0.78	-0.37	-0.48		-0.38	0.79	0.7	-0.8	-0.6	0.83	-0.38	0.8
Net Receivables	0.01	0.08	0.1	-0.33	-0.74	-0.14	0.7	-0.38		-0.43	0.1	0.73	0.69	-0.66	1.0	-0.67
Total Liab	-0.22	-0.52	0.5	0.43	0.66	-0.68	-0.1	0.79	-0.43		0.5	-0.82	-0.58	0.74	-0.43	0.73
Short Term Debt	-0.09	-0.26	1.0	0.19	0.13	-0.68	0.08	0.7	0.1	0.5		-0.2	0.14	0.19	0.1	0.15
Intangible Assets	0.06	0.27	-0.2	-0.63	-0.96	0.16	0.62	-0.8	0.73	-0.82	-0.2		0.91	-0.96	0.73	-0.96
Common Stock	-0.05	0.08	0.14	-0.64	-0.95	-0.2	0.73	-0.6	0.69	-0.58	0.14	0.91		-0.95	0.69	-0.96
Net Invested Capital	0.02	-0.16	0.19	0.7	0.99	-0.02	-0.7	0.83	-0.66	0.74	0.19	-0.96	-0.95		-0.66	1.0
Short Long Term Debt	0.01	0.08	0.1	-0.33	-0.74	-0.14	0.7	-0.38	1.0	-0.43	0.1	0.73	0.69	-0.66		-0.67
Net Working Capital	0.02	-0.15	0.15	0.69	0.99	0.0	-0.71	0.8	-0.67	0.73	0.15	-0.96	-0.96	1.0	-0.67

Click cells to compare fundamentals

About Quoin Pharmaceuticals Financial Statements

Quoin Pharmaceuticals investors use historical fundamental indicators, such as Quoin Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quoin Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	12.2 M	11.7 M
Intangibles To Total Assets	0.05	0.05

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC